
Photo: latimes.com
Aug 31, 2025, 07:05
Pat Soon-Shiong: Expanding Access to Hard-to-Treat Cancers Through CSSIFM Trials
Pat Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman at ImmunityBio, Executive Chairman of Los Angeles Times, shared a post on X:
“In order to provide us much access as possible we have opened randomized trials CSSIFM for the following cancers: non small cell lung cancer in which patients have failed chemo and checkpoint inhibitors / glioblastoma failed surgery, radiation and temodor. Soon advanced colon cancer, papillary bladder cancer failed BCG and HPV positive cancers.”
More posts featuring Pat Soon-Shiong.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 31, 2025, 01:20
Aug 31, 2025, 01:12
Aug 30, 2025, 23:45
Aug 30, 2025, 23:16
Aug 30, 2025, 22:08
Aug 30, 2025, 22:08
Aug 30, 2025, 22:01
Aug 30, 2025, 21:47